Long-term Relapse and Survival in Clinical Stage I Testicular Teratoma
We compared survival rates after testicle removal in clinical stage I testicular cancer for two different tumor types. We found that cancer-specific and overall survival rates were similar for pure teratoma tumors and nonseminoma tumors, and that the recurrence rate was lower for pure teratoma tumors. Our results support surveillance as a suitable option after surgery for patients with clinical stage I testicular teratoma.
Authors
- Padraig Warde (ORCID: https://orcid.org/0000-0002-4236-0026)
- Susan Prendeville (ORCID: https://orcid.org/0000-0002-1068-355X)
- Philippe Lucien Bedard (ORCID: https://orcid.org/0000-0002-6771-2999)
- Eshetu G. Atenafu (ORCID: https://orcid.org/0000-0002-4613-3680)
- Roderick Clark (ORCID: https://orcid.org/0000-0001-7987-375X)
- Julián Chavarriaga (ORCID: https://orcid.org/0000-0003-0363-5485)
- Lynn Anson‐Cartwright (ORCID: https://orcid.org/0000-0002-7726-9695)
- Robert J. Hamilton (ORCID: https://orcid.org/0000-0002-6715-5934)
- Di Jiang (ORCID: https://orcid.org/0000-0002-1950-2292)
- Peter Chung (ORCID: https://orcid.org/0000-0002-3815-7703)
- Martin O’Malley
- Michael Jewett (ORCID: https://orcid.org/0009-0006-7424-9038)
Institutions
- University Health Network (CA)
- Princess Margaret Cancer Centre (CA)
Publication Details
- Journal
- European Urology Focus
- Published
- 2024-10-24
- DOI
- https://doi.org/10.1016/j.euf.2024.10.004
- Citations
- 1
- Primary Topic
- Testicular diseases and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.57